Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Novanta Inc (NOVT)

Novanta Inc (NOVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,663,715
  • Shares Outstanding, K 35,894
  • Annual Sales, $ 881,660 K
  • Annual Income, $ 72,880 K
  • 60-Month Beta 1.31
  • Price/Sales 6.64
  • Price/Cash Flow 37.54
  • Price/Book 8.58
Trade NOVT with:

Options Overview Details

View History
  • Implied Volatility 29.87% ( +0.57%)
  • Historical Volatility 25.97%
  • IV Percentile 52%
  • IV Rank 40.08%
  • IV High 43.01% on 10/25/23
  • IV Low 21.08% on 08/23/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 4
  • Put/Call OI Ratio 0.84
  • Today's Open Interest 328
  • Open Int (30-Day) 314

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.69
  • Number of Estimates 1
  • High Estimate 0.69
  • Low Estimate 0.69
  • Prior Year 0.80
  • Growth Rate Est. (year over year) -13.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
157.50 +1.77%
on 07/01/24
168.81 -5.05%
on 06/12/24
-1.87 (-1.15%)
since 05/31/24
3-Month
146.86 +9.14%
on 04/19/24
173.38 -7.55%
on 04/04/24
-7.67 (-4.57%)
since 04/02/24
52-Week
111.20 +44.15%
on 11/07/23
185.80 -13.73%
on 07/17/23
-23.81 (-12.93%)
since 06/30/23

Most Recent Stories

More News
Novanta: Q1 Earnings Snapshot

Novanta: Q1 Earnings Snapshot

NOVT : 160.29 (+1.58%)
Novanta: Q4 Earnings Snapshot

Novanta: Q4 Earnings Snapshot

NOVT : 160.29 (+1.58%)
Novanta: Q3 Earnings Snapshot

Novanta: Q3 Earnings Snapshot

NOVT : 160.29 (+1.58%)
Novanta: Q2 Earnings Snapshot

Novanta: Q2 Earnings Snapshot

NOVT : 160.29 (+1.58%)
Novanta: Q1 Earnings Snapshot

Novanta: Q1 Earnings Snapshot

NOVT : 160.29 (+1.58%)
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 9, 2023

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 2023 results on Tuesday, May 9,...

NOVT : 160.29 (+1.58%)
Novanta: Q4 Earnings Snapshot

Novanta: Q4 Earnings Snapshot

NOVT : 160.29 (+1.58%)
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2022

Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the fourth...

NOVT : 160.29 (+1.58%)
Novanta Inc. Schedules Earnings Release and Conference Call for Wednesday, March 1, 2023

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its fourth quarter and full year 2022 results on Wednesday,...

NOVT : 160.29 (+1.58%)
Novanta to Present at the CJS Securities 23rd Annual New Ideas for the New Year Investor Conference on Wednesday, January 11, 2023

Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and Chuck...

NOVT : 160.29 (+1.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Novanta Inc. designs, develops, manufactures and sells precision photonic and motion control components and subsystems to original equipment manufacturers in the medical equipment and advanced industrial technology markets. Novanta Inc., formerly known as GSI Group Inc., is based in Bedford, Massachusetts....

See More

Key Turning Points

3rd Resistance Point 163.13
2nd Resistance Point 161.89
1st Resistance Point 161.09
Last Price 160.29
1st Support Level 159.05
2nd Support Level 157.81
3rd Support Level 157.01

See More

52-Week High 185.80
Last Price 160.29
Fibonacci 61.8% 157.31
Fibonacci 50% 148.50
Fibonacci 38.2% 139.70
52-Week Low 111.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar